IDiyas

For the Inventor, By the Inventor

Princeton Junction, NJ, United States of America

Wenxue Wu

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Princeton Jct, NJ (US) (2003)
  • West Windsor, NJ (US) (2010)
  • Princeton, NJ (US) (2010 - 2012)
  • Princeton Junction, NJ (US) (2005 - 2021)

Company Filing History:

goldMedal17 out of 86 
 
Lexicon Pharmaceuticals, Inc.
 patents
silverMedal13 out of 1,829 
 
Schering Corporation
 patents

Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents
1. 12344596 - Solid forms of (S)-1-((2',6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof (2025-07-01),
2. 12312325 - Methods and compounds useful in the synthesis of an AAK1 inhibitor (2025-05-27),
3. 10968192 - Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis (2021-04-06),
4. 8658682 - (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone dihydrate and methods of its use (2014-02-25),
5. 8629156 - Tryptophan hydroxylase inhibitors (2014-01-14),
6. 8575362 - Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds (2013-11-05),
7. 8450532 - Compounds useful in the preparation of tryptophan hydroxylase inhibitors (2013-05-28),
8. 8293878 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors (2012-10-23),
9. 8093280 - Methods of preparing imidazole-based compounds (2012-01-10),
10. 8026347 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors (2011-09-27),
11. 7968729 - 1-phenyl-1H-pyrazole-based compounds (2011-06-28),
12. 7968726 - Methods of preparing imidazole-based bicyclic compounds (2011-06-28),
13. 7951941 - Process for preparing 5-alkyl-7H-pyrrolo[2,3-d] pyrimindine-2-ols (2011-05-31),
14. 7919618 - Synthesis of piperazines, piperidines and related compounds (2011-04-05),
15. 7897763 - Process for the preparation of substituted phenylalanines (2011-03-01),

Title: Wenxue Wu: A Pioneer in Pharmaceutical Innovations

Introduction

Wenxue Wu, based in Princeton Junction, NJ, has made substantial contributions to the field of pharmaceuticals with an impressive portfolio of 28 patents. His innovative approaches to drug formulation and synthesis have led to significant advancements in medicinal chemistry.

Latest Patents

Wu's latest patents focus on intricate chemical compounds and their solid forms. Notably, he has developed crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide, along with methods of their synthesis. Additionally, he has patented methods of preparing (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone dihydrate and its applications.

Career Highlights

Wenxue Wu has worked with prominent companies in the pharmaceutical industry, including Lexicon Pharmaceuticals, Inc. and Schering Corporation. His expertise and innovative thinking have been instrumental in driving forward various research initiatives.

Collaborations

Throughout his career, Wu has collaborated with notable professionals such as Haiming Zhang and Ramanaiah C Kanamarlapudi. These partnerships have fostered a collaborative research environment conducive to cutting-edge developments.

Conclusion

Wenxue Wu's commitment to innovation within the pharmaceutical realm is evident through his numerous patents and collaborations. His work continues to pave the way for advancements in drug development, showcasing the importance of creativity and teamwork in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…